Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
(2021) Annals of Oncology — Vol. 32, n° 4, p. 452-465 (2021)
Files
1-s20-S0923753420432107-main.pdf
Open Access - Adobe PDF
- 544.82 KB
Details
- Authors
- Abstract
- This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC). It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. Treatment algorithms for locoregional and recurrent/metastatic NPC are provided Recommendations were compiled by the authors based on available scientific data and the authors' collective expert opinion.
- Affiliations
Citations
Bossi, P., Chan, A. T., Licitra, L., Trama, A., Orlandi, E., Hui, E. P., Halámková, J., Mattheis, S., Baujat, B., Hardillo, J., Smeele, L., van Herpen, C., Castro, A., & Machiels, J.-P. (2021). Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 32(4), 452-465. https://doi.org/10.1016/j.annonc.2020.12.007 (Original work published 2021)